iNtRON Biotechnology

iNtRON Biotechnology, Inc. is a biopharmaceutical company based in Seongnam, South Korea, established in 1999. The company focuses on the development of innovative treatments and preventive solutions for human diseases, primarily utilizing bacteriophage and endoricin drugs. In addition to its therapeutic endeavors, iNtRON Biotechnology also manufactures molecular diagnostic assays, including real-time PCR and multiplex PCR kits, aimed at the identification of infectious organisms. Through its commitment to advancing healthcare, iNtRON Biotechnology plays a significant role in both the treatment and diagnosis of diseases globally.

Sung-Soo Jang

CEO and President

Kyung-won Yoon

CEO / Vice President

1 past transactions

LISCure Biosciences

Series B in 2020
LISCure Biosciences Co., Ltd., founded in 2018 and based in Seoul, South Korea, specializes in the research and development of bacteria-mediated immunotherapy. The company focuses on creating therapies for a range of health conditions, including tumors, degenerative neurological diseases, autoimmune disorders, and metabolic diseases. LISCure currently has seven medicinal pipelines and two pipelines dedicated to health-functioning food, with plans to introduce additional products in the future. Through its innovative approach, LISCure aims to provide effective treatment options for various serious health issues.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.